Regressive Neuroblastoma: Widely Accepted, Underreported Histology
Neuroblastoma accounts for approximately 8% of all pediatric cancers and up to 15% of pediatric cancer-related deaths in malignant cases; neuroblastoma is the most common malignancy in infancy. Notably, up to 50% of tumors may undergo spontaneous regression without treatment. However, detailed histological descriptions of regressed neuroblastoma remain limited in the literature. We report the histological features of a particularly illustrative case, characterized by edema, mild collagen deposition, evidence of prior hemorrhage, and calcifications. Cellularity was minimal, consisting of rare, scattered mature-appearing ganglion cells, without neuropil or neuroblastic clusters. Accurate recognition of these morphological features in surgical specimens is essential for optimal treatment planning.
Authors
- Danai Papangelopoulou (ORCID: https://orcid.org/0000-0001-5039-4720)
- Oliver Sánchez (ORCID: https://orcid.org/0000-0003-0008-7436)
- Anne‐Laure Rougemont (ORCID: https://orcid.org/0000-0002-1785-792X)
- Jim C. H. Wilde
- Tom Membrez
- Fabienne Gumy‐Pause
Institutions
- University of Geneva (CH)
- University Hospital of Geneva (CH)
- Geneva College (US)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2026-04-29
- DOI
- https://doi.org/10.1002/ccr3.72640
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00